Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/21/2025

Cognitive Behavioral Therapy for Insomnia

Introduction to CBT-I

  • The American College of Physicians (2016) provides a strong recommendation that all patients with chronic insomnia receive CBT-I as the initial treatment intervention, based on moderate-quality evidence 1
  • The American Academy of Sleep Medicine (2017, 2021) designates psychological and behavioral interventions, particularly CBT-I, as the standard of care for chronic insomnia in adults of all ages 2, 3, 4

Evidence of Efficacy

  • CBT-I produces clinically meaningful improvements that are sustained for up to 2 years, unlike pharmacotherapy which shows degradation of benefit after discontinuation 2, 5

Why Other Options Are Incorrect

  • Polysomnography is not indicated as a first-line diagnostic test for chronic insomnia with a clear clinical presentation 4
  • Ferritin level is only relevant if restless legs syndrome is suspected, which is not described in this case 5
  • Melatonin has insufficient evidence to determine efficacy for chronic insomnia 2
  • Oral hypnotic treatment should only be considered after CBT-I has been tried or when CBT-I is unavailable, using shared decision-making 1, 2

Practical Implementation

  • In-person, therapist-led programs are most beneficial, and digital CBT-I is an effective and scalable alternative when in-person therapy is unavailable 3
  • Treatment typically requires 4-8 sessions over 6 weeks 3

Common Pitfalls to Avoid

  • Do not prescribe hypnotics as first-line treatment, as this violates guideline recommendations and deprives patients of more effective, durable therapy 1, 2
  • Do not rely on sleep hygiene education alone, as it lacks efficacy as a single intervention 3, 4
  • Do not expect immediate results, as patients need counseling that improvements are gradual but sustained 3

When to Consider Pharmacotherapy

  • Only after CBT-I has been attempted or when CBT-I is unavailable should pharmacotherapy be considered through shared decision-making 1, 2

REFERENCES

2

clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an american academy of sleep medicine clinical practice guideline. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2017

3

behavioral and psychological treatments for chronic insomnia disorder in adults: an american academy of sleep medicine clinical practice guideline. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021

4

clinical guideline for the evaluation and management of chronic insomnia in adults. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008